Recommended Free Tools
CRISPR is a genome-editing method researchers use to make targeted DNA changes in farm animals, with goals such as disease resistance, heat tolerance, and improved production traits. Those goals are not proof of broad benefits: each claim depends on what was measured, in which animals and conditions, and whether health and welfare were assessed alongside output.
A 2024 review of 212 peer-reviewed articles found that yield, reproduction, and disease resistance were frequent research targets—not that gene-edited animals are widely used or reliably improved. A cattle study reported better thermoregulation and greater body weight in SLICK cattle by 469 days of age, but the reason for the weight difference remains uncertain.
What is CRISPR doing to farm animals?
CRISPR/Cas9 is one genome-editing system. It can be used to introduce, remove, or substitute DNA at a targeted site. Researchers use it to investigate traits including production, reproduction, disease resistance, and adaptation to heat.
A proposed target, a result in a study, and a benefit established across commercial production are different levels of evidence. An edit associated with one desirable trait may also affect other functions, so researchers need to assess the particular alteration and the animals that carry it.
#1 Best Overall
What the research literature targets
Ledesma and Van Eenennaam’s 2024 review analyzed 212 peer-reviewed articles describing living animals produced using gene-editing technologies for agricultural purposes. In that reviewed literature, yield was the most common targeted trait, followed by reproduction and disease resistance.
| Research finding | What it describes |
|---|---|
| 212 peer-reviewed articles | Articles analyzed by Ledesma and Van Eenennaam, 2024 |
| Yield: 32% | Share of targeted traits in the reviewed literature |
| Reproduction: 21% | Share of targeted traits in the reviewed literature |
| Disease resistance: 17% | Share of targeted traits in the reviewed literature |
These percentages describe research targets across multiple animal groups. They are not the percentage of animals improved, the share of farms using gene-edited animals, or evidence that a targeted benefit works in commercial conditions. The review also found CRISPR/Cas9 was the most commonly reported gene-editing system and targeted knockouts were frequent.
Does gene editing make cattle grow faster?
The UK Animal Welfare Committee discusses a study in which researchers introduced the SLICK mutation into Angus and Jersey cattle using CRISPR/Cas9. The committee reports better thermoregulation and greater body weight in the edited animals by 469 days of age, with carcass traits similar or better than those of non-SLICK controls.
This is a reported study result, not proof that gene editing reliably makes cattle grow faster or improves feed efficiency. The committee notes uncertainty about why the cattle were heavier: improved heat regulation may explain it, or changes in prolactin-receptor function may have effects elsewhere.
The Tool Desk
Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →That distinction matters because PRLR has roles related to reproduction, lactation, metabolism, the immune system, behavior, maternal care, and stress response. An edit’s consequences depend on the specific change and the traits measured; association with one desirable outcome does not establish that there are no other effects.
Are gene-edited animals actually healthier?
Disease resistance is one of the major research targets in agricultural gene editing. An edit aimed at blocking a disease pathway may be promising, but a result for a particular line does not show that animals are generally healthier or resistant to other diseases.
PRRS-resistant pigs are one example discussed in the research literature. Their significance should be judged using evidence about infection outcomes, animal health, production conditions, and performance across generations for that specific line. A research result or regulatory listing alone does not establish broad commercial deployment.
What welfare evidence should readers look for?
The Animal Welfare Committee discusses potential benefits of genome editing for animal health, disease resistance, climate adaptation, and productivity, alongside welfare questions that require careful assessment. A useful evaluation asks what was measured, in how many animals and generations, under what conditions, and whether health, fertility, behavior, and welfare were considered alongside output.
Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minutePC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Rank #3
The chicken example shows why a proposed mechanism or an edited cell line is not enough to establish a viable, healthy farm animal. The committee says published data do not demonstrate whether chickens edited to disrupt three ANP32-related genes are viable or whether they have health or welfare issues. That uncertainty should not be turned into a claim that those edits produce healthy, disease-resistant poultry.
How FDA decisions apply to gene-edited animals
In the United States, the FDA says its risk-based oversight covers intentional genomic alterations in animals, including edits made with CRISPR. Its review considers the alteration’s effect on animal health and, where relevant, food safety, as well as whether the product does what its developer claims.
FDA decisions apply to particular alterations and intended uses; they are not blanket approval of gene-edited animals as a class. For example, FDA completed a risk assessment for genome-edited beef cattle and their offspring in March 2022 and said it would exercise enforcement discretion rather than expect an approval application. FDA separately approved the GalSafe pig alteration in 2020. These are distinct regulatory outcomes, not evidence that every gene-edited animal is approved or on the market.
In a May 1, 2024 announcement, Tracey Forfa, director of FDA’s Center for Veterinary Medicine, said: “We recognize that innovations in animal biotechnology offer tremendous opportunities for advancing human and animal health, and that as an agency we need to keep our regulatory approach current with the evolution of the science.” FDA also described its risk-based framework and coordination with USDA for areas of shared authority.
Rank #4
How to assess a CRISPR livestock claim
- Identify the species and exact edit. A broad label such as “gene-edited animal” does not explain what changed.
- Ask what outcome was measured. Distinguish body weight, thermoregulation, disease outcomes, fertility, and welfare.
- Check the evidence level. A proposed mechanism, cell result, individual-animal study, and result across generations are not equivalent.
- Look for uncertainty and trade-offs. Ask whether other functions of the targeted gene or animal welfare were assessed.
- Check the regulatory claim carefully. FDA decisions are specific to an alteration and intended use; risk review, enforcement discretion, and approval are not interchangeable.
FAQ
What is CRISPR doing to farm animals?
Researchers use CRISPR as one genome-editing method to investigate targeted changes for traits such as yield, reproduction, disease resistance, and heat adaptation. A research target is not itself proof of a practical benefit.
Are gene-edited animals actually healthier?
That depends on the specific edit and evidence for the particular animal line. A change intended to reduce susceptibility to one disease does not establish broad health benefits, and health and welfare need to be assessed alongside production outcomes.
Does gene editing make cattle grow faster?
A study discussed by the UK Animal Welfare Committee reported greater body weight in SLICK cattle by 469 days of age. The reason for the difference is uncertain, so it should not be presented as proof that gene editing reliably increases growth or feed efficiency.
Are CRISPR pigs resistant to disease?
PRRS-resistant pigs are one application discussed in the research literature. Claims should be specific to the edit and supported by evidence about disease outcomes, animal health, production conditions, and performance across generations.
Are gene-edited foods approved?
Regulatory decisions are product- and jurisdiction-specific. In the United States, FDA has taken different actions for individual animal alterations; those decisions do not amount to blanket approval of gene-edited foods.
The bottom line
CRISPR research in farm animals targets real production and health questions, but the intended trait is not the same as a proven benefit. The 2024 review maps what researchers have studied; the SLICK cattle example reports specific outcomes while leaving the reason for greater weight uncertain.
Readers should look for evidence on the particular edit, measured outcomes, animal health and welfare, and regulatory status. Claims that gene editing makes farm animals broadly bigger, stronger, or healthier go beyond what these examples establish.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
Free tools Windows power users keep installed
One-click scans. No signup required.
